Related Experiment Video
Updated: May 7, 2026
08:35
Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response
Kristopher A Sarosiek1, Xiaoke Chi, John A Bachman
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA.
Molecular Cell
|October 1, 2013
Summary
The proteins BID and BIM have distinct roles in initiating programmed cell death (apoptosis) by activating specific mitochondrial proteins, BAK and BAX, respectively. This discovery impacts chemotherapy effectiveness in cancer treatment.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Apoptosis is crucial for homeostasis and chemotherapy.
- Mitochondrial apoptosis requires BAK or BAX activation.
- BID and BIM were thought to be redundant activators.
Purpose of the Study:
- To investigate the functional roles of BID and BIM in apoptosis.
- To determine if BID and BIM have distinct activation preferences for BAK and BAX.
- To explore the clinical implications of these findings on chemotherapy response.
Main Methods:
- Utilized cell-based assays to study apoptosis induction.
- Examined the activation of BAK and BAX by BID and BIM.
- Analyzed clinical data correlating BAK1 status with treatment response.
Main Results:
- BID preferentially activates BAK, while BIM preferentially activates BAX.
- Cells lacking BAK show resistance to BID-activated apoptosis agents (e.g., topoisomerase inhibitors, TRAIL).
- Loss of BAK1 in tumors correlates with poorer response to topoisomerase inhibitors.
Conclusions:
- BID and BIM have non-redundant roles in apoptosis.
- Specific activator-protein interactions (BID-BAK, BIM-BAX) are critical for apoptosis.
- Understanding these distinct roles can guide chemotherapy strategies and predict patient response.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...